Cargando…

Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity

Autoimmunity represents a broad category of diseases that involve a variety of organ targets and distinct autoantigens. For patients with autoimmune diseases who fail to respond to approved disease-modifying treatments, autologous hematopoietic stem cell transplantation (AHSCT) after high-dose immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Kristina M., Lu, Tingting, Lim, Noha, Turka, Laurence A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801415/ https://www.ncbi.nlm.nih.gov/pubmed/29456529 http://dx.doi.org/10.3389/fimmu.2018.00100

Ejemplares similares

Regulation of T Cell Homeostasis and Responses by Pten
por: Newton, Ryan H., et al.
Publicado: (2012)

Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT
por: Bonechi, Elena, et al.
Publicado: (2014)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells
por: Fan, Martin Y., et al.
Publicado: (2018)

The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer
por: Gouttefangeas, Cécile, et al.
Publicado: (2023)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT
por: Kvistad, Silje Agnethe Stokke, et al.
Publicado: (2022)

Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT
por: Boberg, Erik, et al.
Publicado: (2021)

Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities
por: Zhang, Xueying, et al.
Publicado: (2021)

Serological biomarkers in autoimmune GFAP astrocytopathy
por: Fu, Cong-Cong, et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
por: Bertolotto, Antonio, et al.
Publicado: (2020)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Costa, Federica, et al.
Publicado: (2018)

Opportunities and Challenges in Democratizing Immunology Datasets
por: Bhattacharya, Sanchita, et al.
Publicado: (2021)

Syphilis vaccine: challenges, controversies and opportunities
por: Ávila-Nieto, Carlos, et al.
Publicado: (2023)

Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist
por: Lu, Yukang, et al.
Publicado: (2023)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
por: Bayati, Fatemeh, et al.
Publicado: (2021)

T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023)

Alveolar macrophages in lung cancer: opportunities and challenges
por: Chang, Cheng-Yen, et al.
Publicado: (2023)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Editorial: Immunity to Cytomegalovirus Infections: Challenges and Therapeutic Opportunities
por: Alonso-Arias, Rebeca, et al.
Publicado: (2022)

Patient genetics shape the autoimmune response in the blistering skin disease pemphigus vulgaris
por: Baker, John, et al.
Publicado: (2023)

The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
por: Jiang, Tianfang, et al.
Publicado: (2018)

Therapeutic Potential of Regulatory T Cells in Preeclampsia—Opportunities and Challenges
por: Robertson, Sarah A., et al.
Publicado: (2019)

Biomarkers in autoimmune diseases of the central nervous system
por: Zhang, Fenghe, et al.
Publicado: (2023)

Editorial: Clinical management, pathogenesis and biomarkers of cardiovascular disease associated with systemic autoimmune disorders
por: Perez-Sanchez, Carlos, et al.
Publicado: (2022)

Engineered T Cell Therapy for Gynecologic Malignancies: Challenges and Opportunities
por: Xu, Yifan, et al.
Publicado: (2021)

Corrigendum: Alveolar macrophages in lung cancer: opportunities and challenges
por: Chang, Cheng-Yen, et al.
Publicado: (2023)

Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs
por: Brockman, Mark A., et al.
Publicado: (2015)

Corrigendum: The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
por: Jiang, Tianfang, et al.
Publicado: (2019)

Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
por: Bertin, Daniel, et al.
Publicado: (2013)

Applications of Protein Microarrays in Biomarker Discovery for Autoimmune Diseases
por: Li, Siting, et al.
Publicado: (2021)

Editorial: Biomarkers in autoimmune diseases of the central nervous system
por: Zhang, Yin-Xi, et al.
Publicado: (2023)

Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014)

Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges
por: Pacella, Ilenia, et al.
Publicado: (2019)

Primary Literature in the Undergraduate Immunology Curriculum: Strategies, Challenges, and Opportunities
por: Rawlings, Jason S.
Publicado: (2019)

Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges
por: Chen, Jiaxuan, et al.
Publicado: (2022)

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
por: Zhang, Xiaomin, et al.
Publicado: (2022)

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges
por: Riet, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07a54inrmplfu0b9901viq1363